Genetic variants of homocysteine/folate metabolism pathway and risk of inflammatory bowel disease: A synopsis and meta-analysis of genetic association studies

Biomarkers

Volumn 15, Issue 1, 2010, Pages 69-79

  Zintzaras, Elias ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CBS; Crohn's disease; Folate; Gene; Homocysteine; Inflammatory bowel disease; Meta analysis; MTHFR; MTR; MTRR; Polymorphism; TCN2; Ulcerative colitis

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ARTICLE; CROHN DISEASE; ENTERITIS; FOLATE METABOLISM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; ULCERATIVE COLITIS;

FOLIC ACID; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HOMOCYSTEINE; HUMANS; INFLAMMATORY BOWEL DISEASES; METABOLIC NETWORKS AND PATHWAYS; RISK;

EID: 75749094714     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547500903297184     Document Type: Article

References (59)

1. Baumgart DC, Carding SR. (2007). Inflammatory bowel disease: cause and immunobiology. Lancet 369:1627-1640
2. Bernstein CN, Sargent M, Vos HL, Rosendaal FR. (2007). Mutations in clotting factors and inflammatory bowel disease. Am J Gastroenterol 102:338-343
3. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. (1997). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 7:3290-3295
4. Chapman J, Clayton D. (2007). Detecting association using epistatic information. Genet Epidemiol 31:894-909.
5. Chen M, Peyrin-Biroulet L, Xia B, Gueant-Rodriguez RM, Bronowicki JP, Bigard MA, Guèant JL. (2008). Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis in central China. BMC Med Genet 9:78.
6. Clayton D, McKeigue PM. (2001). Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 358:1356-1360
7. Cochran WG. (1954). The combination of estimates from different experiments. Biometrics 10:101-129
8. Cooper RS. (2003). Gene-environment interactions and the etiology of common complex disease. Ann Intern Med 139:437-440
9. Cordell HJ, Clayton DG. (2005). Genetic association studies. Lancet 366:1121-1131
10. DerSimonian R, Laird N. (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177-188
11. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH. (2006). A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461-1463
12. Egger M, Juni P, Bartlett C, Holenstein F, Sterne J. (2003). How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Health Technol Assess 7:1-76.
13. Fernández-Miranda C, Martínez Prieto M, Casis Herce B, Sánchez Gómez F, Gómez González P, Martínez López J, Sáenz-López Pérez S, Gómez de la Cá,mara A. (2005). Hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C-T and 1298A-C mutations in patients with inflammatory bowel disease. Rev Esp Enferm Dig 97:497-504.
14. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
15. Gaustadnes M, Kluijtmans LA, Jensen OK, Rasmussen K, Heil SG, Kraus JP, Blom HJ, Ingerslev J, Rüdiger N. (1998). Detection of a novel deletion in the cystathionine beta-synthase (CBS) gene using an improved genomic DNA based method. FEBS Lett 431:175-179
16. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J, Günther S, Prescott NJ, Onnie CM, Häsler R, Sipos B, Fölsch UR, Lengauer T, Platzer M, Mathew CG, Krawczak M, Schreiber S. (2007). A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39:207-211 (Pubitemid 46184351)
17. Harbord RM, Egger M, Sterne JA. (2006). A modified test for smallstudy effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25:3443-3457
18. Hedges LV. Pigott DP. (2001). The power of statistical tests in metaanalysis. Psychol Meth 6:203-217
19. Herrlinger KR, Cummings JR, Barnardo MC, Schwab M, Ahmad T, Jewell DP. (2005). The pharmacogenetics of methotrexate in inflammatory bowel disease. Pharmacogenet Genomics 15:705-711 (Pubitemid 41345322)
20. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603.
21. Juni P, Holenstein F, Sterne J, Bartlett C, Egger M. (2002). Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol 31:115-123
22. Kitsios GD, Zintzaras E. (2009a). Genomic convergence of genomewide investigations for complex traits. Ann Hum Genet 73:514-519
23. Kitsios GD, Zintzaras E. (2009b). Genome-wide association studies: hypothesis. "Free or engaged"? Transl Res 154:161-164
24. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. (1992). Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327:248-254
25. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, Heng HH, Rommens JM, Scherer SW, Rosenblatt DS, Gravel RA. (1998). Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci U S A 95:3059-3064
26. Ma J, Stampfer MJ, Christensen B, Giovannucci E, Hunter DJ, Chen J, Willett WC, Selhub J, Hennekens CH, Gravel R, Rozen R. (1999). A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 8:825-829
27. Mahmud N, Molloy A, McPartlin J, Corbally R, Whitehead AS, Scott JM, Weir DG. (1999). Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 45:389-394
28. Miller JW, Nadeau MR, Smith D, Selhub J. (1994). Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am J Clin Nutr 59:1033-1039
29. Nakano E, Taylor CJ, Chada L, McGaw J, Powers HJ. (2003). Hyperhomocystinemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 37:586-590
30. Namour F, Olivier J, Abdelmouttaleb I, Adjalla C, Debard R, Salvat C, Guéant J. (2001). Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood. Blood 97:1092-1098
31. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH. (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606
32. Papa A, De Stefano V, Danese S, Chiusolo P, Persichilli S, Casorelli I, Zappacosta B, Giardina B, Gasbarrini A, Leone G, Gasbarrini G. (2001). Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease. Am J Gastroenterol 96:2677-2682
33. Peyrin-Biroulet L, Guéant-Rodriguez RM, Chen M, Bronowicki JP, Bigard MA, Guéant JL. (2008). Association of MTRR 66A>G polymorphism with superoxide dismutase and disease activity in patients with Crohn's disease. Am J Gastroenterol 103:399-406.
34. Stipanuk MH. (2004). Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr 24:539-577
35. Stocco G, Martelossi S, Sartor F, Toffoli G, Lionetti P, Barabino A, Fontana M, Decorti G, Bartoli F, Giraldi T, Ventura A. (2006). Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. Dig Dis Sci 51:474-479
36. Törüner M, Erkan O, Soykan I, Bozdayi M, Cetinkaya H, Yurdaydin C, Uzunalimoǧlu O, Ozden A. (2004). Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease. Turk J Gastroenterol 15:250-252
37. Trikalinos TA, Salanti G, Zintzaras E, Ioannidis JP. (2008). Metaanalysis methods. Adv Genet 60:311-334
38. Vecchi M, Sacchi E, Saibeni S, Meucci G, Tagliabue L, Duca F, De Franchis R. (2000). Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci 45:1465-1469
39. Weir B. (1996). Genetic Data Analysis II: Methods for Discrete Population Genetic Data. Sunderland. MA: Sinauer Associates, 1996.
40. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169-172
41. Wellcome Trust Case Control Consortium. (2007). Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39:1329-1337
42. Yasa MH, Bolaman Z, Yukselen V, Kadikoylu G, Karaoglul AO, Batun S. (2007). Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients. Hepatogastroenterology 54:1438-1442
43. Yilmaz S, Bayan K, Tüzün Y, Batun S, Altintaş A. (2006). A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey. J Thromb Thrombolysis 22:205-212
44. Zdoukopoulos N, Zintzaras E. (2008). Genetic risk factors for placental abruption: a HuGE review and meta-analysis. Epidemiology 19:309-323
45. Zintzaras E, Chatzoulis DZ, Karabatsas CH, Stefanidis I. (2005). The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet 50:267-275
46. Zintzaras E, Giannouli S, Rodopoulou P, Voulgarelis M. (2008). The role of MTHFR gene in multiple myeloma. J Hum Genet 53:499-507.
47. Zintzaras E, Ioannidis JP. (2005). Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 28:123-137
48. Zintzaras E, Ioannidis JP. (2008). Meta-analysis for ranked discovery datasets: theoretical framework and empirical demonstration for microarrays. Comput Biol Chem 32:38-46.
49. Zintzaras E, Kitsios G, Stefanidis I. (2006b). Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 48:700-710
50. Zintzaras E, Koufakis T, Ziakas PD, Rodopoulou P, Giannouli S, Voulgarelis M. (2006a). A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. Eur J Epidemiol 21:501-510
51. Zintzaras E, Lau J. (2008a). Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61:634-645
52. Zintzaras E, Lau J. (2008b). Trends in meta-analysis of genetic association studies. J Hum Genet 53:1-9.
53. Zintzaras E, Uhlig K, Koukoulis GN, Papathanasiou AA, Stefanidis I. (2007). Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis. J Hum Genet 52:881-890
54. Zintzaras E, Zdoukopoulos N. (2009). A Field Synopsis and Meta-Analysis of Genetic Association Studies in Peripheral Arterial Disease: The CUMAGAS-PAD Database. Am J Epidemiol 170:1-11.
55. Zintzaras E. (2006a). Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet 51:618-624
56. Zintzaras E. (2007). Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis. Psychiatr Genet 17:69-75.
57. Zintzaras E. (2006b). C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr Genet 16:105-115
58. Zintzaras E. (2006c). Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin Genet 69:327-336
59. Zintzaras E. (2008). Variance estimation of allele-based odds ratio in the absence of Hardy-Weinberg equilibrium. Eur J Epidemiol 23:323-326